• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GBA基因中的突变对帕金森病表型的“剂量”效应。

A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.

作者信息

Thaler Avner, Gurevich Tanya, Bar Shira Anat, Gana Weisz Mali, Ash Elissa, Shiner Tamara, Orr-Urtreger Avi, Giladi Nir, Mirelman Anat

机构信息

Movement Disorders Unit, Neurological Institute, Tel-Aviv Sourasky Medical Center, Israel; Sackler School of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

Movement Disorders Unit, Neurological Institute, Tel-Aviv Sourasky Medical Center, Israel; Sackler School of Medicine, Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, Israel.

出版信息

Parkinsonism Relat Disord. 2017 Mar;36:47-51. doi: 10.1016/j.parkreldis.2016.12.014. Epub 2016 Dec 16.

DOI:10.1016/j.parkreldis.2016.12.014
PMID:28012950
Abstract

OBJECTIVE

Mutations in the GBA gene are associated with Parkinson's disease (PD). A definite description of the clinical characteristics of PD patients who are compound heterozygotes or homozygotes for mutations in the GBA gene (GD-PD) requires further elucidation.

METHODS

We assessed motor, cognitive, olfactory and autonomic functions as well as demographic data and medical history in a cohort of Ashkenazi Jewish PD patients who were screened for seven common mutations in the GBA gene. We then compared three groups of patients (matched for age and disease duration) who were distinguished by their GBA mutation status, idiopathic PD (iPD), GBA heterozygote PD (GBA-PD) and GD-PD.

RESULTS

Out of a total of 1050 AJ PD patients screened, 12 were found to be either homozygotes or compound heterozygotes for mutations in the GBA gene. These patients had an earlier age of onset, more severe motor impairment, poorer cognition and lower olfactory scores. They also had a higher prevalence of REM sleep behavior disorder and higher frequencies of hallucinations compared to both GBA-PD and iPD.

CONCLUSIONS

The severity of PD phenotype is related to the burden of GBA mutations with GD-PD patients manifesting a more severe phenotype.

摘要

目的

GBA基因突变与帕金森病(PD)相关。对于GBA基因(GD-PD)突变的复合杂合子或纯合子的PD患者的临床特征进行确切描述需要进一步阐明。

方法

我们评估了一组接受GBA基因七种常见突变筛查的阿什肯纳兹犹太PD患者的运动、认知、嗅觉和自主神经功能以及人口统计学数据和病史。然后我们比较了三组(按年龄和病程匹配)根据其GBA突变状态区分的患者,即特发性PD(iPD)、GBA杂合子PD(GBA-PD)和GD-PD。

结果

在总共1050名接受筛查的AJ PD患者中,发现12名是GBA基因突变的纯合子或复合杂合子。这些患者发病年龄更早,运动障碍更严重,认知能力更差,嗅觉评分更低。与GBA-PD和iPD相比,他们快速眼动睡眠行为障碍的患病率也更高,幻觉频率更高。

结论

PD表型的严重程度与GBA突变的负担相关,GD-PD患者表现出更严重的表型。

相似文献

1
A "dose" effect of mutations in the GBA gene on Parkinson's disease phenotype.GBA基因中的突变对帕金森病表型的“剂量”效应。
Parkinsonism Relat Disord. 2017 Mar;36:47-51. doi: 10.1016/j.parkreldis.2016.12.014. Epub 2016 Dec 16.
2
Parkinson's disease phenotype is influenced by the severity of the mutations in the GBA gene.帕金森病表型受 GBA 基因突变严重程度的影响。
Parkinsonism Relat Disord. 2018 Oct;55:45-49. doi: 10.1016/j.parkreldis.2018.05.009. Epub 2018 May 17.
3
Comparison of Parkinson risk in Ashkenazi Jewish patients with Gaucher disease and GBA heterozygotes.戈谢病伴 GBA 杂合子的阿什肯纳兹犹太裔帕金森病风险比较。
JAMA Neurol. 2014 Jun;71(6):752-7. doi: 10.1001/jamaneurol.2014.313.
4
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.帕金森病患者同时携带 GBA 和 LRRK2 突变与仅携带其中一种突变相比:风险估计和基因型-表型相关性。
Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13.
5
Features of -associated Parkinson's disease at presentation in the UK study.英国研究中 - 关联帕金森病的发病特征。
J Neurol Neurosurg Psychiatry. 2018 Jul;89(7):702-709. doi: 10.1136/jnnp-2017-317348. Epub 2018 Jan 29.
6
Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.GBA 突变阳性队列中帕金森病前驱临床标志物的演变
JAMA Neurol. 2015 Feb;72(2):201-8. doi: 10.1001/jamaneurol.2014.2950.
7
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
8
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease.临床及病理确诊帕金森病中的葡萄糖脑苷脂酶突变
Brain. 2009 Jul;132(Pt 7):1783-94. doi: 10.1093/brain/awp044. Epub 2009 Mar 13.
9
[The clinical features of Parkinson's disease in patients with mutations and polymorphic variants of GBA gene].[GBA基因发生突变和多态性变异的帕金森病患者的临床特征]
Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(10):81-86. doi: 10.17116/jnevro201711710181-86.
10
, Gaucher Disease, and Parkinson's Disease: From Genetic to Clinic to New Therapeutic Approaches.戈谢病、帕金森病:从遗传学到临床再到新的治疗方法。
Cells. 2019 Apr 19;8(4):364. doi: 10.3390/cells8040364.

引用本文的文献

1
The modifying effect of mutant LRRK2 on mutant GBA1-associated Parkinson disease.突变型LRRK2对突变型GBA1相关帕金森病的修饰作用。
Hum Mol Genet. 2025 May 2. doi: 10.1093/hmg/ddaf062.
2
A PheWAS approach to identify associations of GBA1 variants with comprehensive phenotypes beyond neurological diseases.一种全基因组关联研究方法,用于识别GBA1基因变异与神经系统疾病以外的综合表型之间的关联。
NPJ Parkinsons Dis. 2025 Mar 17;11(1):48. doi: 10.1038/s41531-025-00901-8.
3
Classification and Genotype-Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review.
GBA1基因变异的分类及基因型-表型关系:MDSGene系统评价
Mov Disord. 2025 Apr;40(4):605-618. doi: 10.1002/mds.30141. Epub 2025 Feb 10.
4
A Global Perspective of -Related Parkinson's Disease: A Narrative Review.与[具体内容缺失]相关的帕金森病的全球视角:一篇叙述性综述
Genes (Basel). 2024 Dec 16;15(12):1605. doi: 10.3390/genes15121605.
5
Clinical, mechanistic, biomarker, and therapeutic advances in GBA1-associated Parkinson's disease.GBA1 相关帕金森病的临床、机制、生物标志物和治疗进展。
Transl Neurodegener. 2024 Sep 12;13(1):48. doi: 10.1186/s40035-024-00437-6.
6
Consensus Guidance for Genetic Counseling in GBA1 Variants: A Focus on Parkinson's Disease.GBA1基因变异的遗传咨询共识指南:聚焦帕金森病
Mov Disord. 2024 Dec;39(12):2144-2154. doi: 10.1002/mds.30006. Epub 2024 Sep 11.
7
Clinical prediction of carrier status in Parkinson's disease.帕金森病携带者状态的临床预测
Clin Park Relat Disord. 2024 Apr 11;10:100251. doi: 10.1016/j.prdoa.2024.100251. eCollection 2024.
8
The Genetic Landscape of Sleep Disorders in Parkinson's Disease.帕金森病睡眠障碍的遗传图谱
Diagnostics (Basel). 2024 Jan 3;14(1):106. doi: 10.3390/diagnostics14010106.
9
Long-Term Evaluation of Biomarkers in the Czech Cohort of Gaucher Patients.捷克戈谢病患者队列的生物标志物长期评估。
Int J Mol Sci. 2023 Sep 22;24(19):14440. doi: 10.3390/ijms241914440.
10
GBA1 Variants and Parkinson's Disease: Paving the Way for Targeted Therapy.GBA1基因变异与帕金森病:为靶向治疗铺平道路。
J Mov Disord. 2023 Sep;16(3):261-278. doi: 10.14802/jmd.23023. Epub 2023 Jun 12.